Caladrius Biosciences, Inc. (CLBS) Social Stream



Caladrius Biosciences, Inc. (CLBS): $0.53

0.00 (-0.02%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CLBS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 449

in industry

Caladrius Biosciences Inc (CLBS) Price Targets From Analysts

Use the tables below to see what analysts covering Caladrius Biosciences Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 2 $10 $8 $9 $0.759 1085.77%
2022-03-23 3 $10 $6 $8 $0.759 954.02%

The Trend in the Analyst Price Target


CLBS's average price target has moved up $1.5 over the prior 14 months.

Over the past 51 weeks, CLBS's average upside potential has been 596.1%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-10 1 10 6 8.67 1.50 478%
2021-07-17 1 10 6 8.67 1.40 519.29%
2021-08-07 4 10 10 10.00 1.27 687.4%
2021-09-04 4 10 10 10.00 1.26 693.65%
2021-11-05 3 10 8 9.00 1.13 696.46%

CLBS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


CLBS's average broker recommendation rating improved by 0.58 over the prior 30 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how Caladrius Biosciences Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 297.31% of that group.
  • Caladrius Biosciences Inc's number of analysts covering the stock is higher than 20.85% of Healthcare stocks.
  • Caladrius Biosciences Inc's average analyst price target is higher than 27.08% of Healthcare stocks.
  • CLBS has a lower variance in analysts' estimates than 6.31% of Healthcare stocks.

Stocks similar to Caladrius Biosciences Inc in the Healthcare industry regarding analyst recommendations and price targets are BXRX, PMD, and OPGN.

Make investment decisions regarding CLBS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6108 seconds.